Skip to content
Sign in
Artwork for Headline: HIV
Headline: HIV · August 1 · 2 min

$2.1B Cut & Remissions

This digest is brought to you by the podcast HIV: The Morning After. Donor government HIV funding fell 25% in 2025 — a $2.1 billion drop to $6.2 billion, the steepest single-year fall on record, driven by US cuts. UNAIDS / International AIDS Society / KFF report. Two more men — the Kansas City and Essen patients — appear to be in HIV remission after stem-cell transplants for blood cancer, though the procedure remains too risky to be a general cure. aidsmap / AIDS 2026 / Healio. A once-weekly islatravir/lenacapavir tablet matched a standard daily pill at 48 weeks in two phase 3 trials and could become the first once-weekly oral HIV treatment, though it isn't yet approved. aidsmap and POZ.

0:00-2:20
Play in

transcript

No transcript — this publisher did not publish one.

show notes

This digest is brought to you by the podcast HIV: The Morning After.

  • Donor government HIV funding fell 25% in 2025 — a $2.1 billion drop to $6.2 billion, the steepest single-year fall on record, driven by US cuts. UNAIDS / International AIDS Society / KFF report.
  • Two more men — the Kansas City and Essen patients — appear to be in HIV remission after stem-cell transplants for blood cancer, though the procedure remains too risky to be a general cure. aidsmap / AIDS 2026 / Healio.
  • A once-weekly islatravir/lenacapavir tablet matched a standard daily pill at 48 weeks in two phase 3 trials and could become the first once-weekly oral HIV treatment, though it isn't yet approved. aidsmap and POZ.

links7

more episodes

All episodes